Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health Monitor Liechtenstein.
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications
GlobeNewswire, Inc.
·
January 11, 2021
Preparations on Track for First Half 2021 Commercial Launch of Libmeldy™ (OTL-200), the First Approved Product for Metachromatic Leukodystrophy (MLD) in the EU Filing Strategy for OTL-200 Biologics License Application (BLA) in MLD in the U.S. to...
ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
GlobeNewswire, Inc.
·
November 3, 2020
Companies have completed the EU regulatory application for marketing approval of avacopan Regulatory submission based on positive data from the pivotal Phase-III ADVOCATE trial of avacopan ST. GALLEN, Switzerland and MOUNTAIN VIEW, Calif., Nov....
Dental Consumables Market Growth Outlook: USD 30.47 Billion in 2024 to USD 75.02 Billion by 2032 at 12.4% CAGR
EIN Presswire
·
April 9, 2025
Key Companies covered in dental consumables market are Dentsply Sirona, Institut Straumann AG, ZimVie, Inc., Henry Schein, Inc., Cortex, & others. NY, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- The global dental consumables market was...
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF ULCERATIVE COLITIS
GlobeNewswire, Inc.
·
November 2, 2020
-- Application Based on Results from Pivotal Phase 2b/3 SELECTION Trial -- Foster City, Calif., & Mechelen, Belgium, November 2, 2020, 22.01 CET – Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that...
SIGA Announces Marketing Authorization Filing for oral tecovirimat with the European Medicines Agency for Multiple Indications
GlobeNewswire, Inc.
·
July 30, 2020
- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications - NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health...
Coronavirus - Africa: Liechtenstein donates CHF 40,000 to help developing countries expand trading capacities
African Press Organization
·
July 21, 2020
Download logo Liechtenstein has contributed CHF 40,000 in 2020 to assist developing countries and least-developed countries (LDCs) in enhancing their trading capacities. This donation will finance training workshops and seminars supported by the...
Global Digital Dentistry Market Report: Projected Growth from USD 4.60 Billion in 2024 to USD 9.22 Billion by 2032
EIN Presswire
·
April 1, 2025
Leading companies in the digital dentistry market include 3Shape A/S, Align Technology, Inc., Dentsply Sirona, Envista, Planmeca Oy, AG, and more. NJ, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- The global digital dentistry market size...
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
GlobeNewswire, Inc.
·
February 28, 2025
If granted, IXCHIQ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
Recordati Rare Diseases now holds Isturisa® European MA
GlobeNewswire, Inc.
·
April 8, 2020
Recordati Rare Diseases is now the European Marketing Authorization holder of Isturisa® (osilodrostat) indicated for Adult patients with Endogenous Cushing’s Syndrome Paris, 8 April, 2020 – Recordati Rare Diseases today announces the transfer of...
European Medicines Agency Validates Marketing Authorization Application for Oral, Once-Daily Berotralstat (BCX7353) to Prevent HAE Attacks
GlobeNewswire, Inc.
·
March 30, 2020
RESEARCH TRIANGLE PARK, N.C., March 30, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that the European Medicines Agency (EMA) has validated its marketing authorization application (MAA) submission for approval...
Coronavirus - Africa: Statement on Protecting Sexual and Reproductive Health and Rights and Promoting Gender-Responsiveness in the COVID-19 Crisis
African Press Organization
·
May 6, 2020
Download logo We, the Ministers of South Africa, Sweden, Argentina, Australia, Albania, Belgium, Bolivia, Bosnia-Herzegovina, Cabo Verde, Canada, Cyprus, Czech Republic, Denmark, Finland, Fiji, France, Germany, Greece, Guinea, Italy, Latvia,...
Fish Fund Steering Committee advances work on Call for Proposals, welcomes new members
World Trade Organization
·
May 20, 2025
The agreement on next steps brings the Steering Committee closer to opening its first Call for Proposals. The Fund will receive funding requests for project grants that will support developing and least developed country (LDC) members to implement...
Innovative Healthcare Investment Firm Proposes Dynamic New Directors With Worldwide Reach Who Can Implement Progressive Strategies and Synergies for Rockwell Medical Inc.
GlobeNewswire, Inc.
·
March 16, 2020
NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Medical Resource Acquisition Group, LLC (MRAG) an investment company focused on facilitating the advancement of innovative healthcare companies, announces that it has been receiving overwhelming support...
Liechtenstein Insurance Industry Market 2017- By Plan Future Business Decisions Using the Forecast Figures 2020
EIN Presswire
·
October 2, 2017
PUNE, MAHARASHTRA, INDIA, October 2, 2017 /EINPresswire.com/ -- WiseGuyReports published new report, titled “The Liechtenstein Insurance Industry”. Synopsis 'Governance, Risk and Compliance – The Liechtenstein Insurance Industry ' report is the...
Innovative healthcare investment firm proposes dynamic new directors with worldwide reach who can implement progressive strategies and synergies for Rockwell Medical Inc.
GlobeNewswire, Inc.
·
March 16, 2020
NEW YORK and WIXOM, Mich., March 16, 2020 (GLOBE NEWSWIRE) -- Medical Resource Acquisition Group LLC (MRAG) is a recently formed Delaware company which was specifically incorporated for the purposes of investing in innovative healthcare companies....
Liechtenstein Insurance Industry Market 2017- By Plan Future Business Decisions Using the Forecast Figures
EIN Presswire
·
September 4, 2017
PUNE, MAHARASHTRA, INDIA, September 4, 2017 /EINPresswire.com/ -- WiseGuyReports published new report, titled “The Liechtenstein Insurance Industry”. Synopsis 'Governance, Risk and Compliance – The Liechtenstein Insurance Industry ' report is the...
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
GlobeNewswire, Inc.
·
February 19, 2025
BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive License agreement with CSPC Megalith Biopharmaceutical...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio...
GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
GlobeNewswire, Inc.
·
September 23, 2019
Cannabidiol oral solution is the first plant-derived cannabis-based medicine to be approved by the European Medicines Agency (EMA) Cannabidiol oral solution contains highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the...